• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » July 2004 – The CenterWatch Monthly : Volume 11, Issue 7, July 2004
July 2004 – The CenterWatch Monthly : Volume 11, Issue 7, July 2004

July 2004 – The CenterWatch Monthly : Volume 11, Issue 7, July 2004

$79.00

Product Details

CRC Loss Tied to Heavy Workload

Study coordinator workload has increased dramatically, as a result of electronic data capture (EDC) implementation and more adverse events reporting. Although many sites are offering better pay, flexible hours, and even hiring assistants, more than half of all CRCs are still leaving their positions within three years. CRCs with experience remain difficult to find.

Medical Writing Market Appreciation

The market for medical writing will exceed $400 million in 2004 and is expected to grow at a steady 15% rate, Thomson CenterWatch estimates. CROs and niche providers are optimistic about medical writing due in part to the FDA’s push for more post-marketing safety studies.

Much Work to be Done Before EU Directive Fully Implemented

The May 1st deadline for incorporating the European Union’s Clinical Trials Directive into national legislation has passed, but some of the 25 member states remain behind schedule.

Eye On: Rheumatoid Arthritis

Rheumatoid arthritis affects more than two million Americans. CenterWatch has identified a pipeline of 28 drugs in development for rheumatoid arthritis.

  • Month in Review
  • In the Pipeline
  • Opportunities Underway
  • TrialWatch
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing